These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38372107)

  • 1. TMCO1 regulates cell proliferation, metastasis and EMT signaling through CALR, promoting ovarian cancer progression and cisplatin resistance.
    Sun G; Gong S; Lan S; He Y; Sun Y; Zhang Z
    Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):99-109. PubMed ID: 38372107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
    Ge T; Liu T; Guo L; Chen Z; Lou G
    Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Selected Signaling Proteins on SNAIL 1 and SNAIL 2 Expression in Ovarian Cancer Cell Lines in Relation to Cells' Cisplatin Resistance and EMT Markers Level.
    Kielbik M; Szulc-Kielbik I; Klink M
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TMCO1 expression promotes cell proliferation and induces epithelial-mesenchymal transformation in human gliomas.
    Gao L; Ye Z; Liu JH; Yang JA; Li Y; Cai JY; Wang YX; Tong SA; Deng G; Zhang S; Chen QX
    Med Oncol; 2022 May; 39(5):90. PubMed ID: 35568751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [miR-497 inhibits the growth and metastasis of SGC-7901 human gastric cancer anoikis resistant cells via blocking Wnt/β-catenin signaling pathway].
    Yu L; Xu Y; Yang J; Gao L; Li H; Wang Z; Zhang Z; Ling Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jul; 39(7):617-625. PubMed ID: 37403721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer.
    Malgundkar SH; Burney I; Al Moundhri M; Al Kalbani M; Lakhtakia R; Okamoto A; Tamimi Y
    BMC Cancer; 2020 May; 20(1):374. PubMed ID: 32366234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
    Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
    Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBP43 promotes epithelial ovarian carcinogenesis via activation of β-catenin signaling pathway.
    Xie H; Chen J; Ma C; Zhao J; Cui M
    Cell Biol Int; 2023 Aug; 47(8):1427-1440. PubMed ID: 37186433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of
    Wu L; Ling ZH; Wang H; Wang XY; Gui J
    Cancer Biother Radiopharm; 2019 Dec; 34(10):642-649. PubMed ID: 31549859
    [No Abstract]   [Full Text] [Related]  

  • 11. Calreticulin increases growth and progression of natural killer/T-cell lymphoma.
    Zheng Y; Li C; Xin P; Peng Q; Zhang W; Liu S; Zhu X
    Aging (Albany NY); 2020 Nov; 12(23):23822-23835. PubMed ID: 33221760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
    Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
    J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression.
    Bahar E; Kim JY; Kim HS; Yoon H
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch1 Affects Chemo-resistance Through Regulating Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian cancer cells.
    Qian XQ; Tang SS; Shen YM; Chen LL; Cheng XD; Wan XY
    Int J Med Sci; 2020; 17(9):1215-1223. PubMed ID: 32547317
    [No Abstract]   [Full Text] [Related]  

  • 15. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
    Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
    Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of nuclear β-catenin accumulation in the Twist2-induced ovarian cancer EMT.
    Mao Y; Xu J; Li Z; Zhang N; Yin H; Liu Z
    PLoS One; 2013; 8(11):e78200. PubMed ID: 24244294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Yu J; Han Q; Cui Y
    Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of
    Tian J; Li Z; Jiang Y; Gu W; Kong E; Hao Q; Kong B; Sun L
    Rejuvenation Res; 2022 Oct; 25(5):243-252. PubMed ID: 36039935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosomal L22-like1 (RPL22L1) Promotes Ovarian Cancer Metastasis by Inducing Epithelial-to-Mesenchymal Transition.
    Wu N; Wei J; Wang Y; Yan J; Qin Y; Tong D; Pang B; Sun D; Sun H; Yu Y; Sun W; Meng X; Zhang C; Bai J; Chen F; Geng J; Lee KY; Fu S; Jin Y
    PLoS One; 2015; 10(11):e0143659. PubMed ID: 26618703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
    Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
    Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.